prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, AP Surgical Pathology: Additional Info. CLINICAL HISTORY: Not provided. GROSS EXAMINATION: A. "Sentinel node #1, hot (AF1-3) ", received for frozen section are three. lymph node candidates. One lymph node is bisected and submitted for frozen. section as AF1-AF2, and the remnant sections are submitted in blocks A1-2. Two additional lymph nodes are submitted for frozen section as AF3, and the. remnant is submitted as block A3. B. "Axillary fat", received in formalin is a 11.3 x 4 x 1.5 cm fragment of. yellow-tan adipose tissue which is dissected to reveal one lymph node. candidate measuring 0.8 x 0.7 x 0.5 cm, which is submitted entirely in block. B1. C. "Left breast cancer, two clips medial, one clip inferior, long stitch. lateral, short stitch superior", received in formalin is a 8 cm medial to. lateral, 7 cm superior to inferior, 2.7 cm anterior to posterior lumpectomy. specimen inked as follows: superior-yellow, inferior-red, anterior-blue and. posterior-black. The specimen is sectioned from medial to lateral to reveal a. 2.0 x 1.5 x 1 cm mass lesion located 0.4 cm from the posterior margin, 0.7 cm. from the anterior margin, 2.7 cm from the medial margin, 2.7 cm from the. lateral margin, 1.3 cm from the superior margin and 3.2 cm from the superior. margin. The remainder of the breast tissue demonstrates fibrofatty lobulated. adipose tissue that is otherwise grossly unremarkable. Sections are submitted. as follows per the block diagram: BLOCK SUMMARY: C1-. medial edge. C2-4. representative medial breast. C5-28 mass submitted entirely. C29-31 representative lateral breast. C32-34 lateral edge. D. "Superior medial margin", received in formalin is a 7.2 x 6.4 x 2.3 cm. fragment of adipose tissue with a stitch marking final margin. The final. margin is inked blue and the opposite margin is inked black. Every other. section is submitted in blocks D1-10. E. "Medial and superior margin", received in formalin is a 5.5 x 3.5 x 2.2 cm. fragment of yellow-tan adipose tissue with a stitch in place marking the final. margin. The stitched margin is inked blue, and the opposite margin is inked. black. The specimen is sectioned to reveal no focal lesions. Every other. section is submitted in blocks E1-12. F. "Inferior to lateral margin", received in formalin is a 6.5 x 5.2 x 2.1 cm. fragment of yellow-tan adipose tissue with a suture marking the final. margin. The final margin is inked blue and the opposite margin is inked. black. The specimen is sectioned to reveal no focal lesions. Every other. section is submitted in blocks F1-11. G. "Anterior skin", received in formalin is a 7.5 x 5 x 2 cm unoriented. aggregate of brown skin with subcutaneous tissue that is grossly. unremarkable. Representative sections are submitted in blocks G1-3. INTRA OPERATIVE CONSULTATION: A. "Sentinel node #1, hot and blue": AF1-2 (one lymph node candidate, bisected) -positive for carcinoma. AF3 (two lymph node candidates) -negative for malignancy. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATHOLOGIC STAGE: PROCEDURE: Partial mastectomy, sentinel lymph node biopsy. PATHOLOGIC STAGE (AJCC. Edition) : pT1c pN1a (sn) pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this Institution's Cancer Registry as required for. accreditation by the Commission on Cancer. Pathology stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: A. "SENTINEL LYMPH NODE #1" (BIOPSY) : METASTATIC ADENOCARCINOMA IN ONE OF THREE LYMPH NODES (1/3). SIZE OF METASTASIS: 5 MILLIMETERS. EXTRANODAL INVASION: ABSENT. B. "AXILLARY FAT" (EXCISION) : ONE LYMPH NODE, NO EVIDENCE OF MALIGNANCY (0/1) . SEE COMMENT. COMMENT: The specimen is re-examined and only one lymph node is identified. C. "LEFT BREAST CANCER" (PARTIAL MASTECTOMY) : INVASIVE ADENOCARCINOMA OF THE BREAST. HISTOLOGIC TYPE: DUCTAL. NOTTINGHAM COMBINED HISTOLOGIC GRADE: 3 OF 3. TUBULE FORMATION SCORE: 3. NUCLEAR PLEOMORPHISM SCORE: 3. MITOTIC RATE SCORE: 2. GROSS TUMOR SIZE: 2 x 1.5 X 1 CM. SIZE OF INVASIVE COMPONENT: 2.0 CM. LYMPHATIC/VASCULAR INVASION: ABSENT. MULTIFOCAL TUMOR: ABSENT. IN-SITU CARCINOMA: PRESENT. TYPE OF IN-SITU CARCINOMA: CRIBRIFORM. NUCLEAR GRADE OF IN-SITU CARCINOMA: 3 OF 3. NECROSIS: ABSENT. DCIS EXTENDING OUTSIDE INVASIVE TUMOR MASS: ABSENT. SIZE OF IN-SITU CARCINOMA: NOT APPLICABLE. STATUS OF NON-NEOPLASTIC BREAST TISSUE: INTRADUCTAL PAPILLOMA, RECENT. NEEDLE CORE BIOPSY SITE. SIZE OF BIOPSY: 8 X 7 x 2.7 CM. MICROCALCIFICATIONS: ABSENT. SURGICAL MARGIN STATUS: NEGATIVE (GREATER THAN 2 MM) . ESTROGEN/PROGESTERONE RECEPTOR, CELL CYCLE, EGFR AND HER2/NEU ANALYSIS: PENDING. PARAFFIN BLOCK NUMBER: C14. RESULTS WILL BE ISSUED IN SEPARATE REPORT FROM. D. "SUPERIOR MEDIAL MARGIN, LEFT BREAST" (RE-EXCISION) : BREAST TISSUE, NO EVIDENCE OF MALIGNANCY. FINAL MARGIN FREE OF TUMOR. E. "MEDIAL AND SUPERIOR MARGIN, LEFT BREAST" (RE-EXCISION). BREAST TISSUE, NO EVIDENCE OF MALIGNANCY. FINAL MARGIN FREE OF TUMOR. F. "INFERIOR TO LATERAL" (RE-EXCISION) : BREAST TISSUE, NO EVIDENCE OF MALIGNANCY. FINAL MARGIN FREE OF TUMOR. G. "ANTERIOR SKIN" (BIOPSY) : SKIN AND SUBCUTANEOUS TISSUE, NO EVIDENCE OF MALIGNANCY. FINAL MARGIN IS NEGATIVE FOR MALIGNANCY. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) . ADDENDUM 1: Please see. for results of supplementary. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) .

expanded version (tokens=2068) : 
 The breast pathology report indicates that the patient underwent a partial mastectomy and sentinel lymph node biopsy. The following findings were observed:

- Histological classification: Invasive adenocarcinoma of the breast, histologic type is ductal.
- Subtype: Luminal A
- Necrosis: Absent
- Tumor infiltrating lymphocytes: Not mentioned
- Histological grade: Nottingham Combined Histologic Grade is 3 of 3.
- Nuclear grade: Nuclear Pleomorphism Score is 3 of 3.
- Lymphovascular invasion: Absent
- Calcification: Absent
- Receptor status: Estrogen/progesterone receptor, cell cycle, EGFR, and HER2/NEU analysis reported as pending.
- IHC and ancillary testing results: None reported in this report.

In addition, the report mentions no evidence of malignancy in the axillary fat and the re-excisions (superior medial margin, medial and superior margin, and inferior to lateral margin) performed. The report does not provide information about the patient's age, clinical presentation, or past medical history.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2221) : 
 The breast pathology report shows the patient was diagnosed with invasive luminal A ductal carcinoma in a 2cm mass lesion. The Nottingham combined histologic grade is 3 of 3, and the nuclear pleomorphism score is also 3 of 3. No lymphovascular invasion, necrosis, or calcification observed. Pending results for the ER/PR receptor, EGFR and HER2/NEU analysis. Other margins were free of malignancy, but no IHC and ancillary testing results reported.

